LUCI GRATCH: Open Payments
NPI 1104102961 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,960 in 161 payments from 23 companies in 2025. Trend: 2023 $223 · 2024 $0 · 2025 $3,960
Food & beverage: $3,856Education: $104
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $762 |
| AstraZeneca Pharmaceuticals LP | 22 | $636 |
| ABBVIE INC. | 19 | $345 |
| Amgen Inc. | 18 | $270 |
| Novartis Pharmaceuticals Corporation | 14 | $268 |
| ANI Pharmaceuticals, Inc. | 17 | $266 |
| E.R. Squibb & Sons, L.L.C. | 6 | $248 |
| Organon LLC | 10 | $207 |
| Janssen Scientific Affairs, LLC | 2 | $187 |
| Mallinckrodt Hospital Products Inc. | 5 | $161 |
Products named: SAPHNELO, Bimzelx, TREMFYA, PURIFIED CORTROPHIN GEL, COSENTYX, RINVOQ, HADLIMA, ACTHAR.
Industry payments across OK — which companies pay providers there.
